focus -WSS

focus

author：focus 2025-10-01 12:11:54 - browse：7

Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.

To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Let's speed up science by embracing open access publishing

WSS

Change Healthcare can notify patients about the breach, HHS says

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Ukraine seeks to reclaim its role as a hub for clinical trials

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

focus

focus

hotspot

Activists slam private health insurers over coverage restrictions

Change Healthcare can notify patients about the breach, HHS says

George Santos makes 1st court appearance after pleading not guilty to 13 counts

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Jerome Adams on the need for new antivirals for Covid

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Alkermes shareholders re

Flagship Pioneering startup Sonata Therapeutics lays off 21

Affirmative action in medical school literally saved lives

Letters to First Opinion on caregivers, digital health, and more

knowledge

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Ultragenyx gene therapy for rare liver ailment succeeds in late

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

explore

Wikipedia

focus

entertainment